骨盆底電刺激器市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Pelvic Floor Electric Stimulator Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月01日 | 出版商:

Global Market Insights Inc. | 英文 286 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球骨盆底電刺激器市場估值為 2.441 億美元，預計 2024 年至 2032 年複合年成長率為 11.4%。世界衛生組織強調，到 2030 年，全球每 6 個人就有 1 人年齡在 60 歲或以上。人口結構的轉變，預計到 2020 年，老年人口將從 10 億增加到 14 億，這加劇了骨盆底疾病的盛行率。隨著年齡的成長，他們的肌肉會減弱，組織彈性會降低，增加尿失禁的風險。因此，對為老年人量身定做的治療解決方案的需求不斷增加。

骨盆底電刺激器產業根據產品類型、應用、最終用途和地區進行細分。

在檢查產品類型時，市場區分移動刺激器和固定刺激器。預測顯示，到 2032 年，行動市場將飆升至 4.159 億美元。這種創新的家庭醫療保健解決方案增強了可近性，特別是對於偏遠地區的人們。此外，智慧型手機連接和個人化追蹤等功能不僅能吸引用戶，還能促進持續的參與。鑑於智慧型手機採用率的不斷上升以及對非侵入性治療的傾斜，該細分市場的成長軌跡似乎很陡峭。

骨盆底電刺激器的應用涵蓋尿失禁、神經退化性疾病和性功能障礙。 2023年，尿失禁領域佔據主導地位，估值為1.948億美元。尿失禁盛行率激增，尤其是在老年人中，刺激了對有效非侵入性治療的需求。患者傾向於保守治療，加上醫療保健專業人員對骨盆底電刺激器的認可，進一步推動了他們的使用。意識的提高、診斷率的提高和技術創新也推動了市場的成長。

在美國，骨盆底電刺激器市場預計到 2032 年將達到 2.459 億美元。城市研究所的數據強調了這一趨勢，因為未來40 年，65 歲及以上的人口將增加一倍以上，到2040 年將達到驚人的8,000 萬人。等疾病的盛行率也在增加。

產業生態系統分析
產業影響力
- 成長動力
  - 尿失禁盛行率增加
  - 提高認知舉措
  - 老年人口基數增加
  - 對非侵入性治療方案的需求不斷成長
- 產業陷阱與挑戰
  - 訪問和分發有限
成長潛力分析
監管環境
技術景觀
- 核心技術
- 鄰近技術
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品類型，2021 - 2032

主要趨勢
移動的
固定的

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
尿失禁
神經退化性疾病
性功能障礙

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
診所
家庭護理設置
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Athena Feminine Technologies, Inc.
Axena Health, Inc.
Beacmed srl
Chiaro Technology Limited
Everyway Medical Instruments Co., Ltd.
InControl Medical.
Laborie
Medtronic plc
Nidd Valley Medical
PeriCoach
Shenzhen XFT Medical Limited
TensCare Ltd
The Prometheus Group
Verity Medical Ltd
Zynex, Inc.

簡介目錄

Product Code: 6267

The Global Pelvic Floor Electric Stimulator Market was valued at USD 244.1 million, with an estimated 11.4% CAGR from 2024 to 2032. A significant driver for this market is the rapidly aging global population. The WHO highlights that by 2030, one in every six individuals worldwide will be aged 60 years or older. This demographic transition, with the elderly population projected to swell from 1 billion in 2020 to 1.4 billion, is amplifying the prevalence of pelvic floor disorders. As individuals age, they face weakened muscles and reduced tissue elasticity, heightening the risk of urinary incontinence. Consequently, there is an escalating demand for therapeutic solutions tailored for the elderly.

The pelvic floor electric stimulator industry is segmented based on product type, application, end use , and region.

When examining product types, the market distinguishes between mobile and fixed stimulators. Projections suggest that the mobile segment will soar to USD 415.9 million by 2032. The allure of mobile stimulators lies in their convenience and portability, allowing users to seamlessly integrate pelvic floor exercises into their daily routines. This innovative home healthcare solution enhances accessibility, particularly for those in remote locales. Moreover, features like smartphone connectivity and personalized tracking not only captivate users but also promote consistent engagement. Given the rising smartphone adoption and a tilt towards non-invasive treatments, the segment's growth trajectory appears steep.

Applications of pelvic floor electric stimulators span urinary incontinence, neurodegenerative diseases, and sexual dysfunction. In 2023, the urinary incontinence segment dominated with a valuation of USD 194.8 million. The surging prevalence of urinary incontinence, notably among the elderly, has spurred demand for effective non-invasive treatments. The inclination of patients towards conservative therapies, coupled with healthcare professionals' endorsement of pelvic floor electric stimulators, has further fueled their uptake. The market growth is also buoyed by heightened awareness, better diagnosis rates, and technological innovations.

In the U.S., the pelvic floor electric stimulator market is on track to hit USD 245.9 million by 2032. The U.S. is witnessing a pronounced uptick in its aging demographic, a group more susceptible to pelvic floor disorders. Data from the Urban Institute underscores this trend as the population aged 65 and above is set to more than double in the next four decades, reaching a staggering 80 million by 2040. As this demographic expands, so does the prevalence of conditions like urinary incontinence and pelvic pain, driving the demand for solutions like pelvic floor electric stimulators.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increase in the prevalence of urinary incontinence
  - 3.2.1.2 Increasing awareness initiatives
  - 3.2.1.3 Rise in geriatric population base
  - 3.2.1.4 Growing demand for non-invasive treatment option
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Limited accessibility and distribution
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Mobile
5.3 Fixed

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Urinary incontinence
6.3 Neurodegenerative diseases
6.4 Sexual dysfunction

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Home care settings
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa